Literature DB >> 16569652

Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry.

Christian Spaulding1, Marie-Claude Morice, Bernard Lancelin, Simon El Haddad, Eric Lepage, Sophie Bataille, Jean-Pierre Tresca, Xavier Mouranche, Sandrine Fosse, Mehran Monchi, Nikita de Vernejoul.   

Abstract

AIMS: In acute myocardial infarction (AMI), primary percutaneous transluminal angioplasty (PTCA) is the preferred option when it can be performed rapidly. Because of the limited access to high PTCA volume centres in some areas, it has been suggested that PTCA could be performed in low-volume centres on AMI patients. Little data exist on the validity of this strategy in modern era PTCA. METHODS AND
RESULTS: The Greater Paris area comprises 11 million inhabitants and accounts for 18% of the French population. In 2001, the hospital agency of the Greater Paris area set up a registry of all PTCAs performed in this region. Data from 2001 and 2002 was analysed. Hospitals performing <400 PTCAs per year were classified as low-volume. A case-control analysis (propensity score) compared in-hospital mortality in low- and high-volume centres. A total of 37 848 angioplasty procedures were performed in 44 centres during the study period; 24.7% were performed in low-volume centres. A non-statistically significant trend towards reduced in-hospital mortality was noted in high-volume centres as opposed to low-volume centres: 2.01 vs. 2.42%, P = 0.057. In-hospital mortality rates were significantly different in the sub-group of emergency procedures: 6.75% in high- vs. 8.54% in low-volume centres, P = 0.028. No difference was noted between low- and high-volume centres in non-emergency procedures (0.62 vs. 0.62%, P = 0.99).
CONCLUSION: In the era of modern stenting, a clear inverse relationship exists between hospital PTCA volume and in-hospital mortality after emergency procedures. Tolerance of low-volume thresholds for angioplasty centres with the purpose of providing primary PTCA in AMI should not be recommended, even in underserved areas.

Entities:  

Mesh:

Year:  2006        PMID: 16569652     DOI: 10.1093/eurheartj/ehi843

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

Review 1.  [Acute myocardial infarction: acute coronary intervention at any hospital versus acute coronary intervention at specialized centers only].

Authors:  Ralf Zahn; Uwe Zeymer
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

2.  Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter?

Authors:  Eliano Pio Navarese; Stefano De Servi; Alessandro Politi; Alessandro Martinoni; Giuseppe Musumeci; Enrico Boschetti; Guido Belli; Maurizio D'Urbano; Emanuela Piccaluga; Corrado Lettieri; Silvio Klugmann
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

3.  Development of a Catheterization and Percutaneous Coronary Intervention Registry with a Data Management Approach: A Systematic Review.

Authors:  Alireza Tabatabaei Tabrizi; Hamid Moghaddasi; Reza Rabiei; Babak Sharif-Kashani; And Eslam Nazemi
Journal:  Perspect Health Inf Manag       Date:  2019-01-01

4.  Long-term outcome after drug-eluting stent implantation in comparison with bare metal stents: a single centre experience.

Authors:  Ioannis Tentzeris; Rudolf Jarai; Serdar Farhan; Johann Wojta; Martin Schillinger; Alexander Geppert; Michael Nürnberg; Gerhard Unger; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2010-09-22       Impact factor: 5.460

5.  Primary angioplasty for any patient with ST-elevation myocardial infarction? Guideline-adherent feasibility and impact on mortality in a rural infarction network.

Authors:  Ralf Birkemeyer; Andreas Rillig; Annette Koch; Tomislav Miljak; Markus Kunze; Udo Meyerfeldt; Wolfgang Steffen; Martin Soballa; Carsten Ranke; Roland Prassler; Albert Benzing; Werner Jung
Journal:  Clin Res Cardiol       Date:  2010-07-06       Impact factor: 5.460

6.  Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice.

Authors:  Timm Bauer; Rainer Hoffmann; Claus Jünger; Oliver Koeth; Ralf Zahn; Anselm Gitt; Tobias Heer; Kurt Bestehorn; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2008-11-22       Impact factor: 5.460

7.  Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems.

Authors:  J Lázár; T Szabó; L Kovács; P M Blumberg; T Bíró
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

8.  Short term cost effectiveness of a regional myocardial infarction network.

Authors:  Ralf Birkemeyer; Anke Dauch; Alfred Müller; Manfred Beck; Henrik Schneider; Hueseyin Ince; Werner Jung; Steffen Wahler
Journal:  Health Econ Rev       Date:  2013-04-08

9.  Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention.

Authors:  Morgane Ethgen; Lsabelle Boutron; Philippe Gabriel Steg; Carine Roy; Philippe Ravaud
Journal:  BMC Med Res Methodol       Date:  2009-04-09       Impact factor: 4.615

10.  Development and course of heart failure after a myocardial infarction in younger and older people.

Authors:  Azam Torabi; John Gf Cleland; Alan S Rigby; Nasser Sherwi
Journal:  J Geriatr Cardiol       Date:  2014-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.